Inflammation in cardiac amyloidosis: prognostic marker or therapeutic target?

被引：2
|
作者：
Sinagra, Gianfranco [1 ,2 ]
Fabris, Enrico [1 ,2 ]
机构：
[1] Univ Trieste, Dept Med Surg & Hlth Sci, Str Fiume 447, I-34149 Trieste, Italy
[2] Azienda Sanit Univ Integrata Trieste, Ctr Translat Cardiol, Trieste, Italy
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2018年 / 20卷 / 04期
关键词：
PRIMARY SYSTEMIC AMYLOIDOSIS; LIGHT-CHAIN AMYLOIDOSIS; STAGING SYSTEM;
D O I：
10.1002/ejhf.1062
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：758 / 759
页数：2
相关论文
共 50 条
  • [31] Vitamin D as a Potential Therapeutic Target and Prognostic Marker for Colorectal Cancer
    Bintintan, Vasile V.
    EBIOMEDICINE, 2018, 31 : 11 - 12
  • [32] Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer
    Furukawa, C
    Daigo, Y
    Ishikawa, N
    Kato, T
    Ito, T
    Tsuchiya, E
    Sone, S
    Nakamura, Y
    CANCER RESEARCH, 2005, 65 (16) : 7102 - 7110
  • [33] SGK1 IS A PROGNOSTIC MARKER AND NOVEL THERAPEUTIC TARGET IN MEDULLOBLASTOMA
    Sturm, D.
    Pleier, S.
    Remke, M.
    Witt, H.
    Reifenberger, G.
    Felsberg, J.
    Kulozik, A. E.
    Witt, O.
    Korshunov, A.
    Lichter, P.
    Pfister, S.
    NEURO-ONCOLOGY, 2010, 12 (06) : II56 - II57
  • [34] FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC
    Liu, Jie
    Ouyang, Yeling
    Xia, Zijin
    Mai, Wenhao
    Song, Hongrui
    Zhou, Fang
    Shen, Lichun
    Chen, Kaiting
    Li, Xiaochen
    Zhuang, Shi-Min
    Liao, Jing
    CELLULAR ONCOLOGY, 2024, 47 (02) : 623 - 638
  • [35] COUP-TFII, a prognostic marker and therapeutic target for prostate cancer
    Qin, Jun
    Tsai, Sophia
    Tsai, Ming-Jer
    ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (03) : 360 - 361
  • [36] Survivin expression as a prognostic marker and therapeutic target in malignant pleural mesothelioma
    Coer, A.
    Hmeljak, J.
    Kern, I.
    VIRCHOWS ARCHIV, 2011, 459 : S132 - S133
  • [37] Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
    Vasaikar, Suhas
    Tsipras, Giorgos
    Landazuri, Natalia
    Costa, Helena
    Wilhelmi, Vanessa
    Scicluna, Patrick
    Cui, Huanhuan L.
    Mohammad, Abdul-Aleem
    Davoudi, Belghis
    Shang, Mingmei
    Ananthaseshan, Sharan
    Straat, Klas
    Stragliotto, Giuseppe
    Rahbar, Afsar
    Wong, Kum Thong
    Tegner, Jesper
    Yaiw, Koon-Chu
    Soderberg-Naucler, Cecilia
    BMC CANCER, 2018, 18
  • [38] CDK9 is a prognostic marker and therapeutic target in pancreatic cancer
    Kretz, Anna-Laura
    Schaum, Monika
    Richter, Julia
    Kitzig, Ella F.
    Engler, Christine C.
    Leithaeuser, Frank
    Henne-Bruns, Doris
    Knippschild, Uwe
    Lemke, Johannes
    TUMOR BIOLOGY, 2017, 39 (02)
  • [39] PSMD14 is a novel prognostic marker and therapeutic target in osteosarcoma
    Lai, Jiabin
    Kong, Weike
    Fu, Qiangchang
    Jiang, Zhaochang
    Sun, Bohao
    Ye, Xin
    Kong, Jing
    Wei, Shumei
    Jiang, Lifeng
    DIAGNOSTIC PATHOLOGY, 2024, 19 (01)
  • [40] FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC
    Jie Liu
    Yeling Ouyang
    Zijin Xia
    Wenhao Mai
    Hongrui Song
    Fang Zhou
    Lichun Shen
    Kaiting Chen
    Xiaochen Li
    Shi-Min Zhuang
    Jing Liao
    Cellular Oncology, 2024, 47 : 623 - 638
12345